How to approach drug substance supply in new product introduction (NPI) processes by Giuliana Miglierini A key issue to be faced during pharmaceutical development refers to the supply of the…
Revision of the PIC/S GMP Guide: Annex 13 and Annex 16 by Giuliana Miglierini The entry into force of EU Regulation 536/2014 “Clinical trials”, at the end of January,…